Skip to content
  • Pharma SOP’s
  • Schedule M
  • Pharma tips
  • Pharma Stability Studies

Pharma GMP

Your Gateway to GMP Compliance and Pharmaceutical Excellence

  • Home
  • Quick Guide
  • Toggle search form

Tag: Risk management in GMP

How to Ensure Compliance with Schedule M Revised for Small Pharmaceutical Manufacturers in India

Posted on January 26, 2025 By digi

How to Ensure Compliance with Schedule M Revised for Small Pharmaceutical Manufacturers in India Tips for Small Pharmaceutical Manufacturers to Achieve Schedule M Revised Compliance Introduction to Schedule M Revised The revised Schedule M under the Drugs and Cosmetics Rules, 1945, introduces enhanced Good Manufacturing Practices (GMP) that align with global standards. While these changes…

Read More “How to Ensure Compliance with Schedule M Revised for Small Pharmaceutical Manufacturers in India” »

GMP in India

The Impact of FDA’s Current Good Manufacturing Practices (cGMP) on Pharma Manufacturing

Posted on January 26, 2025 By digi

The Impact of FDA’s Current Good Manufacturing Practices (cGMP) on Pharma Manufacturing Understanding the Impact of FDA cGMP Regulations on Pharmaceutical Manufacturing Introduction to FDA cGMP in Pharma Manufacturing The pharmaceutical industry is highly regulated to ensure that medicines are safe, effective, and of high quality. In the United States, the Food and Drug Administration…

Read More “The Impact of FDA’s Current Good Manufacturing Practices (cGMP) on Pharma Manufacturing” »

GMP in North America (FDA, Health Canada)

The Importance of Documentation for GMP Compliance under EMA and MHRA

Posted on January 26, 2025 By digi

The Importance of Documentation for GMP Compliance under EMA and MHRA Why Documentation is Essential for GMP Compliance with EMA and MHRA Introduction to GMP Documentation Requirements Documentation is the backbone of Good Manufacturing Practices (GMP) compliance in the pharmaceutical industry. Regulatory authorities such as the European Medicines Agency (EMA) and the Medicines and Healthcare…

Read More “The Importance of Documentation for GMP Compliance under EMA and MHRA” »

GMP in Europe (EMA, MHRA)

How to Address Cross-Contamination in GMP Manufacturing for Biologics

Posted on January 26, 2025 By digi

How to Address Cross-Contamination in GMP Manufacturing for Biologics Strategies to Prevent Cross-Contamination in Biologics Manufacturing Under GMP Introduction: The Complexity of Biologics Manufacturing and Cross-Contamination Risks Biologics manufacturing involves complex processes, including cell culture, fermentation, and purification, that make it particularly vulnerable to cross-contamination. Unlike small-molecule drugs, biologics are produced from living organisms, requiring…

Read More “How to Address Cross-Contamination in GMP Manufacturing for Biologics” »

Preventing Cross-Contamination in Pharma

How to Address GMP Violations in African Pharmaceutical Manufacturing

Posted on January 26, 2025 By digi

How to Address GMP Violations in African Pharmaceutical Manufacturing A Step-by-Step Guide to Handling GMP Violations in African Pharmaceutical Manufacturing Introduction to GMP Compliance in Africa Good Manufacturing Practices (GMP) are essential for ensuring the quality, safety, and efficacy of pharmaceutical products. In Africa, regulatory bodies such as the South African Health Products Regulatory Authority…

Read More “How to Address GMP Violations in African Pharmaceutical Manufacturing” »

GMP in Emerging Markets (GCC, Latin America, Africa)

The Impact of Automation on Continuous Improvement in GMP Manufacturing

Posted on January 26, 2025 By digi

The Impact of Automation on Continuous Improvement in GMP Manufacturing How Automation Drives Continuous Improvement in GMP Compliance Introduction: The Role of Automation in GMP Good Manufacturing Practices (GMP) require pharmaceutical manufacturers to maintain strict standards of quality, safety, and regulatory compliance. Achieving and sustaining these standards often involves addressing inefficiencies, minimizing errors, and adapting…

Read More “The Impact of Automation on Continuous Improvement in GMP Manufacturing” »

Continuous Improvement in GMP

How to Use Risk Management to Prevent GMP Non-Conformities

Posted on January 26, 2025 By digi

How to Use Risk Management to Prevent GMP Non-Conformities Preventing GMP Non-Conformities Through Effective Risk Management Introduction Maintaining Good Manufacturing Practices (GMP) compliance is essential for pharmaceutical manufacturers to ensure product quality, regulatory adherence, and patient safety. However, non-conformities—instances where processes or products fail to meet GMP standards—can lead to serious consequences, including regulatory penalties,…

Read More “How to Use Risk Management to Prevent GMP Non-Conformities” »

Risk Management in GMP

How Health Canada GMP Guidelines Help Prevent Drug Recalls

Posted on January 26, 2025 By digi

How Health Canada GMP Guidelines Help Prevent Drug Recalls Preventing Drug Recalls with Health Canada GMP Guidelines Introduction to Drug Recalls and GMP Compliance Drug recalls can have devastating consequences for pharmaceutical manufacturers, patients, and healthcare systems. Recalls often result from deviations in manufacturing processes, quality control failures, or contamination. Health Canada’s Good Manufacturing Practices…

Read More “How Health Canada GMP Guidelines Help Prevent Drug Recalls” »

Health Canada GMP Regulations

How to Use Risk Management to Ensure GMP Compliance in Asia

Posted on January 26, 2025 By digi

How to Use Risk Management to Ensure GMP Compliance in Asia Leveraging Risk Management for GMP Compliance in Asia Introduction to Risk Management in GMP Risk management is a cornerstone of Good Manufacturing Practices (GMP), playing a critical role in identifying, assessing, and mitigating risks that can impact pharmaceutical product quality and patient safety. In…

Read More “How to Use Risk Management to Ensure GMP Compliance in Asia” »

GMP in Asia (PMDA, NMPA, KFDA)

Best Practices for Documenting TQM Processes in Pharmaceutical GMP

Posted on January 26, 2025 By digi

Best Practices for Documenting TQM Processes in Pharmaceutical GMP A Step-by-Step Guide to Documenting TQM Processes for GMP Compliance Introduction: The Importance of Documentation in TQM and GMP In pharmaceutical manufacturing, meticulous documentation is a cornerstone of both Total Quality Management (TQM) and Good Manufacturing Practices (GMP). Documentation ensures transparency, traceability, and regulatory compliance, providing…

Read More “Best Practices for Documenting TQM Processes in Pharmaceutical GMP” »

Total Quality Management (TQM) in GMP

Posts pagination

Previous 1 … 24 25 26 … 99 Next

Menu

  • GMP Basics
    • Introduction to GMP
    • What is cGMP?
    • Key Principles of GMP
    • Benefits of GMP in Pharmaceuticals
    • GMP vs. GxP (Good Practices)
  • Regulatory Agencies & Guidelines
    • WHO GMP Guidelines
    • FDA GMP Guidelines
    • MHRA GMP Guidelines
    • SCHEDULE – M – Revised
    • TGA GMP Guidelines
    • Health Canada GMP Regulations
    • NMPA GMP Guidelines
    • PMDA GMP Guidelines
    • EMA GMP Guidelines
  • GMP Compliance & Audits
    • How to Achieve GMP Certification
    • GMP Auditing Process
    • Preparing for GMP Inspections
    • Common GMP Violations
    • Role of Quality Assurance
  • Quality Management Systems (QMS)
    • Building a Pharmaceutical QMS
    • Implementing QMS in Pharma Manufacturing
    • CAPA (Corrective and Preventive Actions) for GMP
    • QMS Software for Pharma
    • Importance of Documentation in QMS
    • Integrating GMP with QMS
  • Pharmaceutical Manufacturing
    • GMP in Drug Manufacturing
    • GMP for Biopharmaceuticals
    • GMP for Sterile Products
    • GMP for Packaging and Labeling
    • Equipment and Facility Requirements under GMP
    • Validation and Qualification Processes in GMP
  • GMP Best Practices
    • Total Quality Management (TQM) in GMP
    • Continuous Improvement in GMP
    • Preventing Cross-Contamination in Pharma
    • GMP in Supply Chain Management
    • Lean Manufacturing and GMP
    • Risk Management in GMP
  • Regulatory Compliance in Different Regions
    • GMP in North America (FDA, Health Canada)
    • GMP in Europe (EMA, MHRA)
    • GMP in Asia (PMDA, NMPA, KFDA)
    • GMP in Emerging Markets (GCC, Latin America, Africa)
    • GMP in India
  • GMP for Small & Medium Pharma Companies
    • Implementing GMP in Small Pharma Businesses
    • Challenges in GMP Compliance for SMEs
    • Cost-effective GMP Compliance Solutions for Small Pharma Companies
  • GMP in Clinical Trials
    • GMP Compliance for Clinical Trials
    • Role of GMP in Drug Development
    • GMP for Investigational Medicinal Products (IMPs)
  • GMP Blog

Risk management in GMP

  • How Schedule M Revised Impacts Pharmaceutical Research and Development (R&D) in India
  • How to Streamline Your GMP Processes to Meet EMA and MHRA Requirements
  • Future Trends in Schedule M Revised Compliance and Its Impact on the Indian Pharmaceutical Industry
  • How to Build a Culture of GMP Compliance in Pharmaceutical Manufacturing in Europe
  • How Schedule M Revised Contributes to the Overall Quality Assurance of Indian Pharmaceutical Products
  • How to Ensure GMP Compliance for Pharmaceutical Drug Products in Europe
  • The Role of Regulatory Bodies in Enforcing GMP for Pharmaceutical Manufacturing in Europe
  • The Role of Data Integrity in Compliance with Schedule M Revised for Indian Pharmaceutical Manufacturers
  • How MHRA Ensures GMP Compliance in the UK Pharmaceutical Manufacturing Sector
  • Best Practices for GMP Compliance in High-Risk Drug Manufacturing in Emerging Markets

Copyright © 2025 Pharma GMP.

Powered by PressBook WordPress theme